|
|
|
ABOUT US - Company Overview
|
|
Company
Overview |
Curiox is a bioinstrumentation company spun-off from the Institute of Bioengineering and Nanotechnology under the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox is a leader in the development and commercialisation of innovative assay platforms, based on its expertise in surface chemistry and engineering. The company's present offerings include the DropArray™ system, product development programs and R&D collaborations. Curiox's vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.
|
| The Curiox story |
DropArray™ technology was developed by a research group led by Dr Kim Nam Yong at the Institute of Bioengineering and Nanotechnology (IBN). The group subsequently spun-off from IBN in 2008 and formed Curiox Biosystems, backed primarily by Nanostart AG, a renowned venture capital firm in Germany; and Exploit Technologies, the commercializing arm of A*STAR.
Within the first year of its launch, Curiox received positive responses from its beta customers, achieved multiple sales and signed on its first distributor. Presently, the number of laboratories using the DropArray™ platform worldwide is 7 and rising.
Since its launch, Curiox's DropArray™ Technology has contributed to enabling breakthrough clinical research in the field of ophthalmology, and introduced new high throughput products to its pipeline. Curiox aims to continue to strive towards its vision of accelerating research in Life Sciences with its DropArray™ platform - Because research should be just that easy!
|
|
